|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bognár G, Ledniczky G, István G and
Ondrejka P: Molecular mechanisms in development of colorectal
cancer metastasis. Magy Seb. 59:342–349. 2006.(In Hungarian).
PubMed/NCBI
|
|
3
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
4
|
Ohhara Y, Fukuda N, Takeuchi S, Honma R,
Shimizu Y, Kinoshita I and Dosaka-Akita H: Role of targeted therapy
in metastatic colorectal cancer. World J Gastrointest Oncol.
8:642–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moorcraft SY, Ladas G, Bowcock A and Chau
I: Management of resectable colorectal lung metastases. Clin Exp
Metastasis. 33:285–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith JJ and D'Angelica MI: Surgical
management of hepatic metastases of colorectal cancer. Hematol
Oncol Clin North Am. 29:61–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davies JM and Goldberg RM: Treatment of
metastatic colorectal cancer. Semin Oncol. 38:552–560. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng S, Hu B and An HM: Traditional
Chinese medicinal syndromes and treatment in colorectal cancer. J
Cancer Ther. 3:888–897. 2012. View Article : Google Scholar
|
|
10
|
Deng S, Hu B and Shen KP: Pathogenesis and
treatment of colorectal cancer in traditional Chinese medicine.
World Sci Technol Mod Trad Chinese Med Mater Med. 14:1858–1862.
2012.(In Chinese).
|
|
11
|
Hu B, An HM, Shen KP and DU Q: Effects of
Tenglong Buzhong Decoction on proliferation and apoptosis of human
colon carcinoma cell line LS174T. Zhong Xi Yi Jie He Xue Bao.
8:575–580. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu B, An HM, Shen KP and Du Q:
Senescence-inducing effects of Chinese herbal medicine Tenglong
Buzhong Decoction on human colon carcinoma LS-174-T cells and the
mechanism. Zhong Xi Yi Jie He Xue Bao. 8:1048–1052. 2010.(In
Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng S, Hu B, An HM, Du Q, Xu L, Shen KP,
Shi XF, Wei MM and Wu Y: Teng-Long-Bu-Zhong-Tang, a Chinese herbal
formula, enhances anticancer effects of 5-fluorouracil in CT26
colon carcinoma. BMC Complement Altern Med. 13:1282013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu B, Shen KP, Shi XF, Deng S and Wei MM:
Root of Actinidia chinensis induces anoikis in colon
carcinoma RKO cells. Chin J Exp Tradit Med Formul. 19:242–245.
2013.(In Chinese).
|
|
15
|
Hu B, Shen KP, Shi XF, Deng S and Wei MM:
Experimental research of RKO cell anoikis induced by Duchesnea
indica in human colon cancer. World J Integr Trad West Med.
8:69–72. 2013.(In Chinese).
|
|
16
|
Hu B, An HM, Shen KP, Shi XF, Deng S and
Wei MM: Effect of Solanum nigrum on human colon carcinoma
RKO cells. Zhong Yao Cai. 36:958–961. 2013.(In Chinese). PubMed/NCBI
|
|
17
|
Xiao Q and Ge G: Lysyl oxidase,
extracellular matrix remodeling and cancer metastasis. Cancer
Microenviron. 5:261–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cox TR, Gartland A and Erler JT: Lysyl
oxidase, a targetable secreted molecule involved in cancer
metastasis. Cancer Res. 76:188–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ji F, Wang Y, Qiu L, Li S, Zhu J, Liang Z,
Wan Y and Di W: Hypoxia inducible factor 1α-mediated LOX expression
correlates with migration and invasion in epithelial ovarian
cancer. Int J Oncol. 42:1578–1588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Felding-Habermann B: Integrin adhesion
receptors in tumor metastasis. Clin Exp Metastasis. 20:203–213.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Yang M, Ji Q, Fan D, Peng H, Yang
C, Xiong D and Zhou Y: Anoikis induction and metastasis suppression
by a new integrin αvβ3 inhibitor in human melanoma cell line M21.
Invest New Drugs. 29:666–673. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reinmuth N, Liu W, Ahmad SA, Fan F,
Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin
WF and Ellis LM: Alphavbeta3 integrin antagonist S247 decreases
colon cancer metastasis and angiogenesis and improves survival in
mice. Cancer Res. 63:2079–2087. 2003.PubMed/NCBI
|
|
23
|
Mitra SK and Schlaepfer DD:
Integrin-regulated FAK-Src signaling in normal and cancer cells.
Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen YJ and Shi RJ: Ethanol extract from
radix of Actinidia chinensis inhibits cell proliferation and
indeuces apoptosis in human colon carcinoma cell line LoVo. World
Chin J Digest. 20:pp. 1657–1661. 2012, (In Chinese).
|
|
25
|
Tai CJ, Wang CK, Tai CJ, Lin YF, Lin CS,
Jian JY, Chang YJ and Chang CC: Aqueous extract of Solanum
nigrum leaves induces autophagy and enhances cytotoxicity of
cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human
colorectal carcinoma cells. Evid Based Complement Alternat Med.
2013:5147192013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng B, Hu Q, Liu X, Wang L, Chang Q, Li
J, Tang J, Wang N and Wang Y: Duchesnea phenolic fraction
inhibits in vitro and in vivo growth of cervical cancer through
induction of apoptosis and cell cycle arrest. Exp Biol Med
(Maywood). 234:74–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu H, Zhu Y, Zhang T, Zhao Z, Zhao Y,
Cheng P, Li H, Gao H and Su X: Anti-tumor effects of
atractylenolide I isolated from Atractylodes macrocephala in
human lung carcinoma cell lines. Molecules. 18:13357–13368. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu X, Yang Q, Xi Y, Yu K, Wang W, Zhao X
and Kou X: Kanglaite injection combined with chemotherapy versus
chemotherapy alone in the treatment of advanced non-small cell lung
carcinoma. J Cancer Res Ther. 10 Suppl 1:S46–S51. 2014. View Article : Google Scholar
|
|
29
|
Fu F, Wan Y, Mulati and Wu T: Kanglaite
injection combined with hepatic arterial intervention for
unresectable hepatocellular carcinoma: A meta-analysis. J Cancer
Res Ther. 10 Suppl 1:S38–S41. 2014. View Article : Google Scholar
|
|
30
|
Zhan YP, Huang XE, Cao J, Lu YY, Wu XY,
Liu J, Xu X, Xiang J and Ye LH: Clinical safety and efficacy of
Kanglaite® (Coix seed oil) injection combined
with chemotherapy in treating patients with gastric cancer. Asian
Pac J Cancer Prev. 13:5319–5321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin L, Ye M, Wang SM, Ni SM and Wu X:
Mistletoe induces apoptosis by down-regulating the constitutive
activation of nuclear factor-kB in HCT116 cells. Chin J Clin Pharm
Ther. 13:730–734. 2008.(In Chinese).
|
|
32
|
Kim Y, Roh S, Park JY, Kim Y, Cho DH and
Kim JC: Differential expression of the LOX family genes in human
colorectal adenocarcinomas. Oncol Rep. 22:799–804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ward ST, Weston CJ, Hepburn E, Damery S,
Hejmadi RK, Morton DG, Middleton G, Ismail T and Adams DH:
Evaluation of serum lysyl oxidase as a blood test for colorectal
cancer. Eur J Surg Oncol. 40:731–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cox TR and Erler JT: Lysyl oxidase in
colorectal cancer. Am J Physiol Gastrointest Liver Physiol.
305:G659–G666. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bondareva A, Downey CM, Ayres F, Liu W,
Boyd SK, Hallgrimsson B and Jirik FR: The lysyl oxidase inhibitor,
beta-aminopropionitrile, diminishes the metastatic colonization
potential of circulating breast cancer cells. PLoS One.
4:e56202009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Finger EC and Giaccia AJ: Hypoxia,
inflammation, and the tumor microenvironment in metastatic disease.
Cancer Metastasis Rev. 29:285–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ley K, Rivera-Nieves J, Sandborn WJ and
Shattil S: Integrin-based therapeutics: Biological basis, clinical
use and new drugs. Nat Rev Drug Discov. 15:173–183. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Iwamoto DV and Calderwood DA: Regulation
of integrin-mediated adhesions. Curr Opin Cell Biol. 36:41–47.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ramsay AG, Marshall JF and Hart IR:
Integrin trafficking and its role in cancer metastasis. Cancer
Metastasis Rev. 26:567–578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hsu AR, Veeravagu A, Cai W, Hou LC, Tse V
and Chen X: Integrin alpha v beta 3 antagonists for anti-angiogenic
cancer treatment. Recent Pat Anticancer Drug Discov. 2:143–158.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wai PY, Mi Z, Guo H, Sarraf-Yazdi S, Gao
C, Wei J, Marroquin CE, Clary B and Kuo PC: Osteopontin silencing
by small interfering RNA suppresses in vitro and in vivo CT26
murine colon adenocarcinoma metastasis. Carcinogenesis. 26:741–751.
2005. View Article : Google Scholar : PubMed/NCBI
|
